البلدان النامية في مواجهة الأزمات الصحية في ظل اتفاقية تريبس : حالة جائحة كوفيد 19

Abstract EN

This paper discusses The impacts of Implementation of the provisions related to public health in the Trade-Related Intellectual Property Rights Protection Agreement in developing countries and trying to read and analyze the attitudes of both developing and developed countries on the issue of intellectual property in the light of the current circumstances of the Covid-19 pandemic, where countries are competing to develop an appropriate vaccine.

These attitudes will reflect the ability to face a health crisis in the future.

The study concludes that the pharmaceutical companies' attitudes and the governmental behaviors of developed countries during the Covid-19 pandemic indicate there is no desire to waive or suspending intellectual property rights globally for COVID-19 vaccines.

This confirms its monopolistic tendency and its preference for commercial interests over the public interest even if in circumstances of a global health crisis.